Table 3.
Actigraphic and subjective sleep quality variables
| Wrist Actigraphy | Exercise Training |
Stretching |
g | ||
|---|---|---|---|---|---|
| BL | POST | BL | POST | ||
| TST, min | 398.3 (10.4) | 390.2 (9.3) | 388.3 (17.9) | 385.3 (45.9) | −0.25 |
| SOL, min | 8.2 (1.4) | 5.2 (0.7)* | 10.0 (3.2) | 11.9 (12.7) | −0.52 |
| WASO, min | 57.4 (4.9) | 54.9 (4.8) | 63.5 (10.4) | 63.5 (39.3) | −0.08 |
| SE, % | 85.8 (1.2) | 86.7 (1.1)* | 84.1 (2.0) | 83.8 (7.1) | 0.17 |
| Napping, min | 29.0 (4.3) | 26.7 (5.2) | 30.7 (6.9) | 31.2 (32.6) | −0.12 |
| Fragmentation index | 42.4 (3.4) | 41.1 (2.9)* | 53.4 (9.0) | 55.1 (35.2) | −0.12 |
| Pittsburgh Sleep Quality Index | |||||
| Poor sleep quality, prevalence | 48% | 29% | 75% | 75% | |
| Global score, 0-21 | 6.2 (0.6) | 4.7 (0.5)* | 8.1 (1.0) | 8.0 (1.0) | −0.43 |
| Sleep quality, 0-3 | 1.6 (0.1) | 1.0 (0.2)* | 1.6 (0.2) | 1.4 (0.2) | −0.60 |
| Sleep latency, 0-3 | 0.7 (0.2) | 0.5 (0.1)* | 1.3 (0.3) | 1.4 (0.3) | −0.32 |
| Sleep duration, 0-3 | 0.5 (0.1) | 0.4 (0.1) | 1.1 (0.3) | 1.0 (0.2) | 0.07 |
| Sleep efficiency, 0-3 | 0.2 (0.1) | 0.2 (0.1) | 0.8 (0.3) | 0.6 (0.3) | 0.26 |
| Sleep disturbances, 0-3 | 1.6 (0.1) | 1.4 (0.1)* | 1.6 (0.2) | 1.8 (0.1) | −0.62 |
| Sleep medications, 0-3 | 0.4 (0.2) | 0.3 (0.2) | 0.4 (0.3) | 0.6 (0.3) | −0.24 |
| Daytime dysfunction, 0-3 | 1.3 (0.1) | 0.9 (0.1) | 1.3 (0.2) | 1.3 (0.2) | −0.48 |
All data are presented as mean (standard error) unless otherwise noted. A PSQI global score > 5 was considered to be poor sleep quality.28 SE, sleep efficiency; SOL, sleep onset latency; TST, total sleep time; WASO, wakefulness after sleep onset.
*
Statistically significant difference between treatments at post-intervention following control for baseline values (P < 0.05).